Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review-Reference-Cited by-同舟云学术

Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review

Published:2022-09-10 Issue: Volume: Page:
ISSN:0021-1265
Container-title:Irish Journal of Medical Science (1971 -)
language:en
Short-container-title:Ir J Med Sci

Author:

Mali Kalpana Ramanna,Eerike Madhavi^ORCID,Raj Gerard Marshall^ORCID,Bisoi Debasis,Priyadarshini Rekha^ORCID,Ravi Gandham,Chaliserry Leo Francis,Janti Siddharam S.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11845-022-03139-y.pdf

Reference36 articles.

1. Crotty S, Cameron CE, Andino R (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98(12):6895–6900. https://doi.org/10.1073/pnas.111085598

2. Agostini ML, Pruijssers AJ, Chappell JD et al (2019) Small-molecule antiviral β-d-N4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance. J Virol 26;93(24):e01348-19

3. Toots M, Yoon JJ, Hart M et al (2020) Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model. Transl Res 18:16e28. https://doi.org/10.1016/j.trsl.2019

4. Painter WP, Holman W, Bush JA et al (2021) Human safety, tolerability, and pharmacokinetics of molnupiravir, a novel broad-spectrum oral antiviral agent with activity against SARS-CoV-2. Antimicrob Agents Chemother 65(5):e02428-e2520. https://doi.org/10.1128/AAC.02428-20

5. FDA (2022) Fact sheet for healthcare providers: emergency use authorization for molnupiravir (fda.gov). Available from: https://www.fda.gov/media/155054/download

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Degradation of antiviral drug molnupiravir using a dual function FeIIFeIIILDH@carbon felt cathode in the heterogeneous electro-Fenton process: Kinetics and mineralization study;Journal of Environmental Chemical Engineering;2024-10

2. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

3. Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study;Italian Journal of Medicine;2024-06-03

4. Antiviral properties of milk proteins and peptides against SARS-COV-2: A review;Journal of Functional Foods;2024-06

5. Molnupiravir detection by tandem mass spectrometry;Archives of Current Medical Research;2024-05-31